PharmaBoardroom

Interview with Catherine Bourrienne-Bautista, Managing Director,…

Generic drugs were a very late arrival for the French market in comparison with other European markets and healthcare systems on a par with the French…

Interview with Jean-Pierre Cassan, Honrary President of the LEEM,…

Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical…

Interview with André Choulika, President, France Biotech

France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your…

Interview with Christian Rodié, FEFIS – Fédération…

FEFIS represents 11 different associations across the industry with a very broad scope. How does the organization represent all of these different…

Interview with Noël Renaudin, President, Comité Economique des…

The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the…

Interview with Jean Marimbert, Director General, Agence…

The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the market.…

Argentina – Where Crisis Brings Opportunity

Boasting three Nobel Prize winners from the life sciences, Argentina has had a long history of innovation. Immigration from Europe at the…

Jean-François Dehecq – Chairman, Sanofi-Aventis

What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them?…

Interview with Wolfgang Söhngen, CEO, Paion

Why was the time right in 2000 to start Paion, and how did your background and experiences in the pharma industry, academia and consulting help you…

Interview with Martin Stapf, Global BU Director Oncology, Hikma…

One of the biggest recent milestones for Hikma’s global operations must have been the acquisition of Ribosepharm and Thymoorgan in 2007. How…

Interview with Thomas Klein, Ceo and Founder, Cytolon

You have a wide professional experience that goes from financial adviser to biotechnology entrepreneur, passing through software business and…

Interview with Klaus Heumann, Founder and CEO, Biomax Informatics

Your interest in bioinformatics has run though your academic career and now into your business career as CEO and founder of Biomax Informatics; what…

Tagged with